175 related articles for article (PubMed ID: 33063010)
1. Clinical and molecular characterization of a multi-institutional cohort of pediatric spinal cord low-grade gliomas.
Grob ST; Nobre L; Campbell KR; Davies KD; Ryall S; Aisner DL; Hoffman L; Zahedi S; Morin A; Crespo M; Nellan A; Green AL; Foreman N; Vibhakar R; Hankinson TC; Handler MH; Hawkins C; Tabori U; Kleinschmidt-DeMasters BK; Mulcahy Levy JM
Neurooncol Adv; 2020; 2(1):vdaa103. PubMed ID: 33063010
[TBL] [Abstract][Full Text] [Related]
2. Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomas.
Tian Y; Rich BE; Vena N; Craig JM; Macconaill LE; Rajaram V; Goldman S; Taha H; Mahmoud M; Ozek M; Sav A; Longtine JA; Lindeman NI; Garraway LA; Ligon AH; Stiles CD; Santagata S; Chan JA; Kieran MW; Ligon KL
J Mol Diagn; 2011 Nov; 13(6):669-77. PubMed ID: 21884820
[TBL] [Abstract][Full Text] [Related]
3. Pediatric low-grade gliomas can be molecularly stratified for risk.
Yang RR; Aibaidula A; Wang WW; Chan AK; Shi ZF; Zhang ZY; Chan DTM; Poon WS; Liu XZ; Li WC; Zhang RQ; Li YX; Chung NY; Chen H; Wu J; Zhou L; Li KK; Ng HK
Acta Neuropathol; 2018 Oct; 136(4):641-655. PubMed ID: 29948154
[TBL] [Abstract][Full Text] [Related]
4. KIAA1549-BRAF fusions and IDH mutations can coexist in diffuse gliomas of adults.
Badiali M; Gleize V; Paris S; Moi L; Elhouadani S; Arcella A; Morace R; Antonelli M; Buttarelli FR; Figarella-Branger D; Kim YH; Ohgaki H; Mokhtari K; Sanson M; Giangaspero F
Brain Pathol; 2012 Nov; 22(6):841-7. PubMed ID: 22591444
[TBL] [Abstract][Full Text] [Related]
5. Chromosome band 7q34 deletions resulting in KIAA1549-BRAF and FAM131B-BRAF fusions in pediatric low-grade Gliomas.
Roth JJ; Santi M; Pollock AN; Harding BN; Rorke-Adams LB; Tooke LS; Biegel JA
Brain Pathol; 2015 Mar; 25(2):182-92. PubMed ID: 25040262
[TBL] [Abstract][Full Text] [Related]
6. Frequent BRAF gain in low-grade diffuse gliomas with 1p/19q loss.
Kim YH; Nonoguchi N; Paulus W; Brokinkel B; Keyvani K; Sure U; Wrede K; Mariani L; Giangaspero F; Tanaka Y; Nakazato Y; Vital A; Mittelbronn M; Perry A; Ohgaki H
Brain Pathol; 2012 Nov; 22(6):834-40. PubMed ID: 22568401
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological analysis of BRAF and non-BRAF MAPK pathway-altered gliomas in paediatric and adult patients: a single-institution study of 40 patients.
Ali RH; Almanabri M; Ali NY; Alsaber AR; Khalifa NM; Hussein R; Alateeqi M; Mohammed EMA; Jama H; Almarzooq A; Benobaid N; Alqallaf Z; Ahmed AA; Bahzad S; Almurshed M
J Clin Pathol; 2024 Jan; ():. PubMed ID: 38195220
[TBL] [Abstract][Full Text] [Related]
8. The potential of liquid biopsy for detection of the KIAA1549-BRAF fusion in circulating tumor DNA from children with pilocytic astrocytoma.
Krynina O; de Ståhl TD; Jylhä C; Arthur C; Giraud G; Nyman P; Fritzberg A; Sandgren J; Tham E; Sandvik U
Neurooncol Adv; 2024; 6(1):vdae008. PubMed ID: 38371226
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliomas.
Kumar A; Pathak P; Purkait S; Faruq M; Jha P; Mallick S; Suri V; Sharma MC; Suri A; Sarkar C
Cancer Genet; 2015 Mar; 208(3):91-5. PubMed ID: 25794445
[TBL] [Abstract][Full Text] [Related]
10. BRAF alterations in pediatric low grade gliomas and mixed neuronal-glial tumors.
Dimitriadis E; Alexiou GA; Tsotsou P; Simeonidi E; Stefanaki K; Patereli A; Prodromou N; Pandis N
J Neurooncol; 2013 Jul; 113(3):353-8. PubMed ID: 23612919
[TBL] [Abstract][Full Text] [Related]
11. Incidence of kiaa1549-braf fusion gene in Egyptian pediatric low grade glioma.
Taha H; Yehia M; Mahmoud M; El-Beltagy M; Ghabriel M; El-Naggar S
Clin Transl Med; 2015; 4():10. PubMed ID: 25883769
[TBL] [Abstract][Full Text] [Related]
12. MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomas.
Tatevossian RG; Tang B; Dalton J; Forshew T; Lawson AR; Ma J; Neale G; Shurtleff SA; Bailey S; Gajjar A; Baker SJ; Sheer D; Ellison DW
Acta Neuropathol; 2010 Dec; 120(6):731-43. PubMed ID: 21046410
[TBL] [Abstract][Full Text] [Related]
13. Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas.
Lazow MA; Hoffman L; Schafer A; Osorio DS; Boué DR; Rush S; Wright E; Lane A; DeWire-Schottmiller MD; Smolarek T; Sipple J; Taggert H; Reuss J; Salloum R; Hummel TR; de Blank P; Pillay-Smiley N; Sutton ME; Asher A; Stevenson CB; Drissi R; Finlay JL; Fouladi M; Fuller C
Acta Neuropathol Commun; 2020 Nov; 8(1):182. PubMed ID: 33153497
[TBL] [Abstract][Full Text] [Related]
14. BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma.
Mistry M; Zhukova N; Merico D; Rakopoulos P; Krishnatry R; Shago M; Stavropoulos J; Alon N; Pole JD; Ray PN; Navickiene V; Mangerel J; Remke M; Buczkowicz P; Ramaswamy V; Guerreiro Stucklin A; Li M; Young EJ; Zhang C; Castelo-Branco P; Bakry D; Laughlin S; Shlien A; Chan J; Ligon KL; Rutka JT; Dirks PB; Taylor MD; Greenberg M; Malkin D; Huang A; Bouffet E; Hawkins CE; Tabori U
J Clin Oncol; 2015 Mar; 33(9):1015-22. PubMed ID: 25667294
[TBL] [Abstract][Full Text] [Related]
15. Novel RAF Fusions in Pediatric Low-Grade Gliomas Demonstrate MAPK Pathway Activation.
Lind KT; Chatwin HV; DeSisto J; Coleman P; Sanford B; Donson AM; Davies KD; Willard N; Ewing CA; Knox AJ; Mulcahy Levy JM; Gilani A; Green AL
J Neuropathol Exp Neurol; 2021 Dec; 80(12):1099-1107. PubMed ID: 34850053
[TBL] [Abstract][Full Text] [Related]
16. Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification.
Gierke M; Sperveslage J; Schwab D; Beschorner R; Ebinger M; Schuhmann MU; Schittenhelm J
J Cancer Res Clin Oncol; 2016 Jan; 142(1):89-100. PubMed ID: 26115961
[TBL] [Abstract][Full Text] [Related]
17. Multiplex Detection of Pediatric Low-Grade Glioma Signature Fusion Transcripts and Duplications Using the NanoString nCounter System.
Ryall S; Arnoldo A; Krishnatry R; Mistry M; Khor K; Sheth J; Ling C; Leung S; Zapotocky M; Guerreiro Stucklin A; Lassaletta A; Shago M; Tabori U; Hawkins CE
J Neuropathol Exp Neurol; 2017 Jul; 76(7):562-570. PubMed ID: 28863456
[TBL] [Abstract][Full Text] [Related]
18. Surgical and molecular considerations in the treatment of pediatric thalamopeduncular tumors.
Lee RP; Foster KA; Lillard JC; Klimo P; Ellison DW; Orr B; Boop FA
J Neurosurg Pediatr; 2017 Sep; 20(3):247-255. PubMed ID: 28686121
[TBL] [Abstract][Full Text] [Related]
19. Establishment and application of a novel patient-derived KIAA1549:BRAF-driven pediatric pilocytic astrocytoma model for preclinical drug testing.
Selt F; Hohloch J; Hielscher T; Sahm F; Capper D; Korshunov A; Usta D; Brabetz S; Ridinger J; Ecker J; Oehme I; Gronych J; Marquardt V; Pauck D; Bächli H; Stiles CD; von Deimling A; Remke M; Schuhmann MU; Pfister SM; Brummer T; Jones DT; Witt O; Milde T
Oncotarget; 2017 Feb; 8(7):11460-11479. PubMed ID: 28002790
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic application of high resolution single nucleotide polymorphism array analysis for children with brain tumors.
Roth JJ; Santi M; Rorke-Adams LB; Harding BN; Busse TM; Tooke LS; Biegel JA
Cancer Genet; 2014 Apr; 207(4):111-23. PubMed ID: 24767714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
